MOORESTOWN, N.J., Sept. 13, 2021 /PRNewswire/ -- Tabula Rasa
HealthCare, Inc.® (TRHC) (NASDAQ: TRHC), hosted its
16th CareKinesis Clinical Advisory Panel (CAP) Meeting,
September 9-10, 2021, bringing
together Program of All-Inclusive Care for the Elderly (PACE)
medical directors from across the country.
The two-day advisory panel was held in person in Scottsdale, AZ and virtually, enabling a
compelling exchange of insights between PACE medical directors and
TRHC to help prepare for changes in PACE and today's healthcare
environment, to provide updates on TRHC service enhancements, and
to share science and practice advances.
"The CareKinesis CAP meeting provides PACE medical directors
with updates on our continued success measurably improving patient
outcomes through effective delivery of clinical pharmacy products
and services, both inside and outside of PACE," said TRHC
Co-Founder and President, Orsula V.
Knowlton, PharmD. "This highly anticipated event provides us
with a unique opportunity to engage with PACE medical directors to
discuss opportunities to embrace enhanced models of patient
care."
Attendees heard an overview of TRHC's Medication Risk Mitigation
(MRM) Matrix™ and participated in robust discussions focusing on
medication safety and the important clinical consideration when
deprescribing certain medications.
PACE medical directors also participated in important case
discussions on the clinical impact and benefits of Pharmacogenetics
(PGx) testing for opioids and psychotropic drug utilization and
prevention of adverse drug events in older adults. Other sessions
included discussions on the benefits of collaborative practice
agreements between pharmacists and physicians, optimizing
management of kidney failure in PACE, and keeping PACE participants
safe during transitions of care.
In addition, attendees learned more about TRHC's latest
peer-reviewed publications. They received an overview of current
research from TRHC Precision Pharmacotherapy Research &
Development Institute which will enable PACE medical directors to
apply the latest data to their use of the MedWise Risk Score™ in
collaboration with board-certified pharmacists.
The CAP Meeting is a training and education event for PACE
medical directors. CME, ACPE and CNE continuing education credits
are available to participants.
PACE is a managed care program that provides a comprehensive,
all-inclusive package of medical and supportive services to
individuals aged 55 or older who are certified by their state to
need nursing home care, are able to live safely in the community at
the time of enrollment, and live in a PACE service area.
CareKinesis is the first national PACE-centric, medication
management and distribution pharmacy that focuses on reducing
medication-related risk while enhancing economic, clinical, and
humanistic outcomes.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) (NASDAQ: TRHC) provides medication
safety solutions that empower healthcare professionals and
consumers to optimize medication regimens, combatting medication
overload and reducing adverse drug events – the fourth leading
cause of death in the US. TRHC's proprietary technology solutions,
including MedWise®, improve patient outcomes, reduce
hospitalizations, and lower healthcare costs. TRHC's extensive
clinical tele-pharmacy network improves care for patients
nationwide. Its solutions are trusted by health plans and
pharmacies to help drive value-based care. For more information,
visit TRHC.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/trhc-hosts-pace-medical-directors-at-2021-clinical-advisory-panel-meeting-301375387.html
SOURCE Tabula Rasa HealthCare, Inc.